Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia

Eunice S. Wang, Richard Aplenc, Deborah Chirnomas, Michael Dugan, Salman Fazal, Swaminathan Iyer, Tara L. Lin, Sucha Nand, Kristen J. Pierce, Paul J. Shami, Jennifer J. Vermette, Camille N. Abboud

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences